Guillaumet-Adkins, Amy <br/><br/>
Hypermethylation of the alternative AWT1 promoter in hematological malignancies is a highly specific marker for acute myeloid leukemias despite high expression levels.  [electronic resource] 

 -  Journal of hematology & oncology  Jan 2014 
 - 4 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1756-8722 
<br/><br/><label>Standard No.: </label>10.1186/1756-8722-7-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Alternative Splicing<br/>Biomarkers, Tumor--genetics<br/>Child<br/>Child, Preschool<br/>CpG Islands--genetics<br/>DNA Methylation<br/>Female<br/>Gene Expression Regulation, Neoplastic<br/>HL-60 Cells<br/>Hematologic Neoplasms--genetics<br/>Humans<br/>K562 Cells<br/>Leukemia, Myeloid--genetics<br/>Male<br/>Middle Aged<br/>Promoter Regions, Genetic--genetics<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>U937 Cells<br/>WT1 Proteins--genetics<br/>Young Adult